Table 4.
ISWT reference values for HF patients according to age, gender and presence of any significant comorbidity groups.
| Patient characteristics | Mean | SD | Percentile 05 | Percentile 25 | Percentile 75 | Percentile 95 | Count | ||
|---|---|---|---|---|---|---|---|---|---|
| Young HF ≤65 | Male | COPD + Asthma | 302.17 | 166.45 | 70 | 180 | 375 | 670 | 88 |
| Metabolic | 313.49 | 160.19 | 80 | 180 | 420 | 630 | 230 | ||
| Musculoskeletal | 301.15 | 173.49 | 30 | 180 | 420 | 630 | 128 | ||
| None-of-the-above comorbidities | 377.65 | 180.46 | 80 | 250 | 520 | 640 | 356 | ||
| Female | COPD + Asthma | 224.44 | 141.91 | 60 | 90 | 320 | 520 | 36 | |
| Metabolic | 228.14 | 127.68 | 60 | 130 | 300 | 520 | 59 | ||
| Musculoskeletal | 216.76 | 113.94 | 60 | 120 | 305 | 420 | 68 | ||
| None-of-the-above comorbidities | 310.39 | 150.06 | 70 | 210 | 420 | 550 | 140 | ||
| Old HF 65+ | COPD + Asthma | 226.30 | 126.95 | 50 | 120 | 320 | 490 | 125 | |
| Metabolic | 235.91 | 126.97 | 60 | 150 | 330 | 420 | 325 | ||
| Musculoskeletal | 220.20 | 133.08 | 50 | 120 | 280 | 450 | 210 | ||
| None-of-the-above comorbidities | 263.90 | 144.54 | 70 | 170 | 350 | 520 | 291 | ||
| Female | COPD + Asthma | 149.35 | 98.19 | 30 | 70 | 180 | 350 | 46 | |
| Metabolic | 167.54 | 88.42 | 40 | 100 | 220 | 330 | 95 | ||
| Musculoskeletal | 174.21 | 97.26 | 40 | 90 | 240 | 340 | 113 | ||
| None-of-the-above comorbidities | 226.94 | 118.83 | 50 | 140 | 310 | 420 | 121 |